Industry Threat Report: Healthcare

whitePaper | September 19, 2022

Across all industries, and particularly in healthcare, companies are looking to tap into their data assets and drive intelligent decision making across the organization.

whitePaper | May 18, 2022

Post-COVID conditions, also known by such terms as long COVID and post-acute sequelae of COVID-19, have become an issue of growing national concern. Until recently, researchers were limited by the lack of a specific ICD-10 diagnosis code for post-COVID conditions.

whitePaper | June 3, 2022

With increased scrutiny from regulatory agencies, advocacy groups and the public for clinical trial transparency, sponsors are feeling the pressure to ramp up efforts to make their studies more accessible.

whitePaper | January 4, 2023

The Centers for Medicare & Medicaid Services (CMS) relies on data to inform planning and execution of policies that affect more than 170 million individuals enrolled in CMS programs nationwide, including but not limited to Medicare, Medicaid & the Children’s Health Insurance Program (CHIP)

whitePaper | November 19, 2022

Now, more than ever, sponsors and CROs need to prioritize including patient engagement in their study builds from the ground-up. This involves defining processes to remove barriers for access.

whitePaper | August 17, 2022

Medical Affairs and medical science liaisons (MSLs) are highly visible and important roles that have faced significant obstacles in recent years trying to engage healthcare providers.